Research Articles | Aplastic Anemia & MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Effectiveness and safety of tacrolimus with or without eltrombopag, as a part of immunosuppressive treatment of aplastic anemia in adults: a retrospective case series Jan 2021 Annals of Hematology aplastic anemia
Paroxysmal nocturnal hemoglobinuria: current treatments and unmet needs Dec 2020 Journal of Managed care and specialty pharmacy paroxysmal nocturnal hemoglobinuria (PNH)
Paroxysmal nocturnal hemoglobinuria: patient journey and burden of disease Dec 2020 Journal of Managed care and specialty pharmacy paroxysmal nocturnal hemoglobinuria (PNH)
Paroxysmal nocturnal hemoglobinuria: role of the complement system, pathogenesis, and pathophysiology Dec 2020 Journal of Managed care and specialty pharmacy paroxysmal nocturnal hemoglobinuria (PNH)
One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab Dec 2020 European Journal of Haematology paroxysmal nocturnal hemoglobinuria (PNH)
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria Dec 2020 Blood, cells, molecules & diseases paroxysmal nocturnal hemoglobinuria (PNH)
Parsing the Paradox of Myelodysplastic Syndromes Dec 2020 Journal of clinical oncology: official journal of the American Society Clinical Oncologysd myelodysplastic syndromes (MDS)
Outpatient transfusions for myelodysplastic syndromes Dec 2020 Hematology. American Society of Hematology. Education Program myelodysplastic syndromes (MDS)
Patient stratification in myelodysplastic syndromes: how a puzzle may become a map Dec 2020 Hematology. American Society of Hematology. Education Program myelodysplastic syndromes (MDS)
Therapy for lower-risk MDS Dec 2020 Hematology. American Society of Hematology. Education Program myelodysplastic syndromes (MDS)